SEC Form 5/A · accession 0000899243-18-004461
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Anastasios Gianakakos
Officer — CEO and President · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 16, 2018 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2017 | G | 181,169 | $0.00 | D | 0 | I | By Reporting Person's Trust 1 |
| Common Stock | Nov 20, 2017 | G | 144,569 | $0.00 | A | 653,686 | D | |
| Common Stock | Nov 20, 2017 | G | 12,200 | $0.00 | A | 12,200 | I | By Trust 1 |
| Common Stock | Nov 20, 2017 | G | 12,200 | $0.00 | A | 12,200 | I | By Trust 2 |
| Common Stock | Nov 20, 2017 | G | 12,200 | $0.00 | A | 12,200 | I | By Trust 3 |
| Common Stock | Dec 4, 2017 | M | 6,677 | $1.5068 | A | 660,363 | D | |
| Common Stock | Dec 7, 2017 | G | 6,677 | $0.00 | D | 653,686 | D | |
| Common Stock | Dec 7, 2017 | G | 6,677 | $0.00 | A | 6,677 | I | By Reporting Person's Trust 2 |
| Common Stock | Dec 15, 2017 | G | 579,296 | $0.00 | D | 74,390 | D | |
| Common Stock | Dec 15, 2017 | G | 579,296 | $0.00 | A | 585,973 | I | By Reporting Person's Trust 2 |
| Common Stock | Dec 22, 2017 | G | 500,000 | $0.00 | D | 85,973 | I | By Reporting Person's Trust 2 |
| Common Stock | Dec 22, 2017 | G | 500,000 | $0.00 | A | 574,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.5068 | Dec 4, 2017 | M | 6,677 | D | — | Jun 3, 2025 | Common Stock | 6,677 | 151,235 | D |
Explanation of responses
- F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F225% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019.